Aberrant gene expression involved in purine metabolism, such as ADA and CD73 expression, has been reported in PD-affected brain regions [90, 221] (Table 1), suggesting a primary manifestation or compensatory effects of altered purine metabolism in PD. The gene discussed is ADA; the disease is Parkinson disease.